Incyte Corp. diskutieren
Incyte Corp.
WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
59,42 €
-0,47 %
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $83.00 price target on the stock, down previously from $84.00.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at TD Cowen from $88.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, down previously from $52.00.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $84.00 to $81.00. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Citigroup Inc. from $80.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Neueste Beiträge
StockNews_com in Clean Harbors diskutieren